Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Rose AMC, Pozo F, Martínez-Baz I, Mazagatos C, Bossuyt N, Cauchi JP, Petrović G, Loghin II, Vaikutyte R, Buda S, Machado A, Duffy R, Oroszi B, Howard J, Echeverria A, Andreu C, Barbezange C, Džiugytė A, Nonković D, Popescu CP, Majauskaite F, Tolksdorf K, Gomez V, Domegan L, Horváth JK, Castilla J, García M, Demuyser T, Borg ML, Tabain I, Lazar M, Kubiliute I, Dürrwald R, Guiomar R, O'Donnell J, Kristóf K, Nicolay N, Bacci S, Kissling E; VEBIS SARI VE network team; Belgium SARI Surveillance Network (BelsariNet). Rose AMC, et al. Among authors: nicolay n. Influenza Other Respir Viruses. 2024 Feb;18(2):e13255. doi: 10.1111/irv.13255. Influenza Other Respir Viruses. 2024. PMID: 38403302 Free PMC article.
Initial assessment of the COVID-19 vaccination's impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021.
Nicolay N, Innocenti F, Beauté J, Učakar V, Grgič Vitek M, Poukka E, Hannila-Handelberg T, Gauci C, Melillo T, Georgakopoulou T, Jarkovsky J, Slezak P, Delgado-Sanz C, Olmedo-Lucerón C, Suija H, Liausediene R, O'Lorcain P, Murphy N, Peralta-Santos A, Casaca P, Gregoriou I, Bundle N, Spiteri G, Ravasi G. Nicolay N, et al. Euro Surveill. 2021 Dec;26(48):2101030. doi: 10.2807/1560-7917.ES.2021.26.48.2101030. Euro Surveill. 2021. PMID: 34857068 Free PMC article.
Systematic review of the efficacy, effectiveness and safety of recombinant haemagglutinin seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
O Murchu E, Comber L, Jordan K, Hawkshaw S, Marshall L, O'Neill M, Ryan M, Teljeur C, Carnahan A, Pérez JJ, Robertson AH, Johansen K, Jonge J, Krause T, Nicolay N, Nohynek H, Pavlopoulou I, Pebody R, Penttinen P, Soler-Soneira M, Wichmann O, Harrington P. O Murchu E, et al. Among authors: nicolay n. Rev Med Virol. 2023 May;33(3):e2331. doi: 10.1002/rmv.2331. Epub 2022 Feb 2. Rev Med Virol. 2023. PMID: 35106885 Review.
Systematic review of the efficacy, effectiveness and safety of high-dose seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
Comber L, O Murchu E, Jordan K, Hawkshaw S, Marshall L, O'Neill M, Teljeur C, Ryan M, Carnahan A, Pérez Martín JJ, Robertson AH, Johansen K, de Jonge J, Krause T, Nicolay N, Nohynek H, Pavlopoulou I, Pebody R, Penttinen P, Soler-Soneira M, Wichmann O, Harrington P. Comber L, et al. Among authors: nicolay n. Rev Med Virol. 2023 May;33(3):e2330. doi: 10.1002/rmv.2330. Epub 2022 Feb 4. Rev Med Virol. 2023. PMID: 35119149 Review.
Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
Jordan K, Murchu EO, Comber L, Hawkshaw S, Marshall L, O'Neill M, Teljeur C, Harrington P, Carnahan A, Pérez-Martín JJ, Robertson AH, Johansen K, Jonge J, Krause T, Nicolay N, Nohynek H, Pavlopoulou I, Pebody R, Penttinen P, Soler-Soneira M, Wichmann O, Ryan M. Jordan K, et al. Among authors: nicolay n. Rev Med Virol. 2023 May;33(3):e2332. doi: 10.1002/rmv.2332. Epub 2022 Feb 8. Rev Med Virol. 2023. PMID: 35137512 Review.
Systematic review of the efficacy, effectiveness and safety of MF59® adjuvanted seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.
O Murchu E, Comber L, Jordan K, Hawkshaw S, Marshall L, O'Neill M, Ryan M, Teljeur C, Carnahan A, Pérez JJ, Robertson AH, Johansen K, Jonge J, Krause T, Nicolay N, Nohynek H, Pavlopoulou I, Pebody R, Penttinen P, Soler-Soneira M, Wichmann O, Harrington P. O Murchu E, et al. Among authors: nicolay n. Rev Med Virol. 2023 May;33(3):e2329. doi: 10.1002/rmv.2329. Epub 2022 Feb 10. Rev Med Virol. 2023. PMID: 35142401
239 results